Omeros (OMER) Receivables - Net (2010 - 2026)
Omeros recorded quarterly Receivables - Net of $12.0 million in Q1 2026, up 10.21% quarter-over-quarter from $10.9 million in Q4 2025, and up 70.04% year-over-year from $7.1 million in Q1 2025.
Omeros' Receivables - Net history runs 17 years deep, the most recent figure standing at $12.0 million for Q1 2026.
- In Q1 2026, Receivables - Net rose 70.04% year-over-year to $12.0 million; the TTM figure through Mar 2026 stood at $12.0 million (up 70.04% YoY), while the FY2025 annual figure was $10.9 million, up 41.06% from the prior year.
- Receivables - Net came in at $12.0 million for Q1 2026 at Omeros, up from $10.9 million in the prior quarter.
- In the past five years, Receivables - Net ranged from a high of $213.2 million in Q4 2022 to a low of $6.3 million in Q2 2025.
- A 5-year average of $21.6 million and a median of $8.1 million in 2023 frame the typical range for Receivables - Net.
- Across the five-year window, Receivables - Net jumped 20501.06% in 2022 and tumbled 96.2% in 2023, its largest moves.
- Omeros' Receivables - Net stood at $213.2 million in 2022, then sank by 96.2% to $8.1 million in 2023, then dropped by 4.41% to $7.7 million in 2024, then surged by 41.06% to $10.9 million in 2025, then advanced by 10.21% to $12.0 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $12.0 million, $10.9 million, and $6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.03 Mn |
| Mar 31, 2026 | 12.03 Mn |
| Dec 31, 2025 | 10.92 Mn |
| Dec 31, 2025 | 10.92 Mn |
| Sep 30, 2025 | 6.91 Mn |
| Sep 30, 2025 | 6.91 Mn |
| Jun 30, 2025 | 6.28 Mn |
| Jun 30, 2025 | 6.28 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Mar 31, 2025 | 7.08 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Dec 31, 2024 | 7.74 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Sep 30, 2024 | 6.39 Mn |
| Jun 30, 2024 | 8.08 Mn |
| Jun 30, 2024 | 8.08 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Mar 31, 2024 | 7.64 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Dec 31, 2023 | 8.10 Mn |
| Sep 30, 2023 | 6.88 Mn |
| Sep 30, 2023 | 6.88 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Jun 30, 2023 | 11.20 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Mar 31, 2023 | 10.00 Mn |
| Dec 31, 2022 | 213.22 Mn |
| Dec 31, 2022 | 213.22 Mn |
| Sep 30, 2022 | 13.90 Mn |
| Sep 30, 2022 | 13.90 Mn |
| Jun 30, 2022 | 14.50 Mn |
| Jun 30, 2022 | 14.50 Mn |
| Mar 31, 2022 | 16.26 Mn |
| Mar 31, 2022 | 16.26 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 33.62 Mn |
| Sep 30, 2021 | 33.62 Mn |
| Jun 30, 2021 | 31.84 Mn |
| Jun 30, 2021 | 31.84 Mn |
| Mar 31, 2021 | 24.58 Mn |
| Mar 31, 2021 | 24.58 Mn |
| Dec 31, 2020 | 3.77 Mn |
| Dec 31, 2020 | 3.77 Mn |
| Sep 30, 2020 | 37.38 Mn |
| Sep 30, 2020 | 37.38 Mn |
| Jun 30, 2020 | 15.78 Mn |
| Jun 30, 2020 | 15.78 Mn |
| Mar 31, 2020 | 24.01 Mn |
| Mar 31, 2020 | 24.01 Mn |
| Dec 31, 2019 | 35.07 Mn |
| Dec 31, 2019 | 35.07 Mn |
| Sep 30, 2019 | 29.93 Mn |
| Sep 30, 2019 | 29.93 Mn |
| Jun 30, 2019 | 28.38 Mn |
| Jun 30, 2019 | 28.38 Mn |
| Mar 31, 2019 | 24.72 Mn |
| Mar 31, 2019 | 24.72 Mn |
| Dec 31, 2018 | 22.82 Mn |
| Dec 31, 2018 | 22.82 Mn |
| Sep 30, 2018 | 2.30 Mn |
| Sep 30, 2018 | 2.30 Mn |
| Jun 30, 2018 | 1.53 Mn |
| Jun 30, 2018 | 1.53 Mn |
| Mar 31, 2018 | 182,000.00 |
| Mar 31, 2018 | 182,000.00 |
| Dec 31, 2017 | 17.14 Mn |
| Dec 31, 2017 | 17.14 Mn |
| Sep 30, 2017 | 24.57 Mn |
| Sep 30, 2017 | 24.57 Mn |
| Jun 30, 2017 | 19.08 Mn |
| Jun 30, 2017 | 19.08 Mn |
| Mar 31, 2017 | 13.48 Mn |
| Mar 31, 2017 | 13.48 Mn |
| Dec 31, 2016 | 12.04 Mn |
| Dec 31, 2016 | 12.04 Mn |
| Sep 30, 2016 | 10.46 Mn |
| Sep 30, 2016 | 10.46 Mn |
| Jun 30, 2016 | 8.81 Mn |
| Jun 30, 2016 | 8.81 Mn |
| Mar 31, 2016 | 6.65 Mn |
| Mar 31, 2016 | 6.65 Mn |
| Dec 31, 2015 | 6.52 Mn |
| Dec 31, 2015 | 6.52 Mn |
| Sep 30, 2015 | 2.51 Mn |
| Sep 30, 2015 | 2.51 Mn |
| Jun 30, 2015 | 3.07 Mn |
| Jun 30, 2015 | 3.07 Mn |
| Mar 31, 2015 | 538,000.00 |
| Mar 31, 2015 | 538,000.00 |
| Dec 31, 2014 | 392,000.00 |
| Dec 31, 2014 | 392,000.00 |
| Sep 30, 2014 | 381,000.00 |
| Sep 30, 2014 | 381,000.00 |
| Jun 30, 2014 | 252,000.00 |
| Jun 30, 2014 | 252,000.00 |
| Mar 31, 2014 | 488,000.00 |
| Mar 31, 2014 | 488,000.00 |
| Dec 31, 2013 | 379,000.00 |
| Dec 31, 2013 | 379,000.00 |
| Sep 30, 2013 | 881,000.00 |
| Sep 30, 2013 | 881,000.00 |
| Jun 30, 2013 | 715,000.00 |
| Jun 30, 2013 | 715,000.00 |
| Mar 31, 2013 | 2.00 Mn |
| Mar 31, 2013 | 2.00 Mn |
| Dec 31, 2012 | 1.93 Mn |
| Dec 31, 2012 | 1.93 Mn |
| Sep 30, 2012 | 467,000.00 |
| Sep 30, 2012 | 467,000.00 |
| Jun 30, 2012 | 767,000.00 |
| Jun 30, 2012 | 767,000.00 |
| Mar 31, 2012 | 1.64 Mn |
| Mar 31, 2012 | 1.64 Mn |
| Dec 31, 2011 | 876,000.00 |
| Dec 31, 2011 | 876,000.00 |
| Sep 30, 2011 | 776,000.00 |
| Sep 30, 2011 | 776,000.00 |
| Jun 30, 2011 | 2.46 Mn |
| Jun 30, 2011 | 2.46 Mn |
| Dec 31, 2010 | 1.48 Mn |
| Dec 31, 2010 | 1.48 Mn |